|
| CMN-0001-24 | 09/01/2024 | SCM | Permanent | Major | Additional source induction | Myoinositol | We are currently procuring nutraceutical material Myoinositol from M/s. Zouping Xiwang Bioengineering co ltd China. | we intend to induct one more source M/s SICHUAN BOHAODA BIOTECHNOLOGY CO LTD ADD: NO.9 LONGXIANG AVENUE, HIGH-TECH INDUSTRIAL PARK, Zigong city, sichuan, China | N/A | Approved | 30/01/2026 | Opened | Nutra | 1) specification agreement required 2) PD trial required 3) Trial batch stability report required 4) valid GMP certificate from country of origin. 6) valid DML required 7) Halal certificate required 8) quality agreement required 9) vendor list will be updated. 10) procurement of material for commercial batches. 11) process validation will be performed 12) product will charge on stability.
|
|
| 09/01/2024 | 20/02/2024 | Hafsa Fatima | Hafsa Fatima |
|
| CMN-0002-24 | 16/01/2024 | SCM | Permanent | Major | Additional source induction | Simethicone Emulsion 30% | We want to procure '' Simethicone Emulsion 30%'' for our nutraceutical product Evojoshanda sachet. | we intend to induct this source M/s Nitika pharmaceutical specialties pvt ltd Add: Block No: 03 of plot no: 1296, 1297/08, ward no 03, Mouza-Waddhamna Tah-Hingna, Amravati road, Nagpur 440023, india for the material simethicone Emulsion 30% | N/A | Approved | 29/02/2024 | Opened | Nutra | 1) Specification agreement will be signed before approval of the source. 2) Sample testing report is required. 3) DMF will arrange. 4) PD Trial on new source is required with Stability studies report. 5) Valid DML is required. 6) Valid GMP certificate from country of origin. 7) Quality agreement is required. 8) Supplier Questionnaire form will be developed to receive the required information. 9) List of approved supplier/materials will be developed and circulated to all concerns departments. 10) Strength with amount of material required for process validation. 11) Procurement of material to conduct commercial batch manufacturing. 12) Planning of batches to be taken for process validation on new source 13) Process validation will be performed. 14) Stability of product will be charged.
|
|
| 16/01/2024 | 26/03/2024 | Hafsa Fatima | Hafsa Fatima |
|
| CMN-0003-24 | 04/03/2024 | Business Development | Permanent | Major | Launch Of New product in Kazakhstan | The product is mentioned in the attached list are not launch in Kazakhstan
1) Ferfer sachet
2) Reklaim sachet
3) Adfolic tablet | These products are planned for launch in Kazakhstan | N/A | Approved | | Opened | Nutra | Product launch in Kazakhstan 2. Development and approval of artwork QC PKG 3. Regulatory approval required RA 4. Item code will open for new developed artwork QC PKG 5. FG codes will be opened SCM 6. Specification will be updated QC PKG 7. BOM will create on SAP QA 8. BPR will be prepared QA
|
| 1-APR-2024
2-APR-2024
3-MAR-2024
4-APR-2024
5-MAR-2024
6-JUL-2024
7-MAY-2024
8-MAY-2024
| 04/03/2024 | 22/04/2024 | Hafsa Fatima | Hafsa Fatima |
|
| CMN-0004-24 | 25/03/2024 | SCM | permanent | major | Additional source induction of D-chiro Inositol | we are currently procuring nutraceutical material D- Chiro inositol from M/s.BIO SEARCH S.A | we intendto induct one more source M/s M/s hebei amino biotechnology Co.,Ltd, Add; East Huangguan Rd; North Huigong Ave., Qinghe Auto and Motor Industrial area, Xingtai City, Hebei Province, P.R. China / 054800 | N/A | Approved | 30/06/2025 | Opened | Nutra | 1.
Source approval documents are required along with all the technical documents SCM
2. Approved vendor list will update QA
3. Procurement of material to conduct commercial batch manufacturing SCM
4. Process validation will be performed QA
5. Stability of product will be charged QC
6) LIMS will be updated
|
| 1) April-2024
2) April-2024
3) April-2025
4) June-2025
5) June-2025
6) June-2025
| 27/03/2024 | 24/04/2024 | Hafsa Fatima | Hafsa Fatima |
|
| CMN-0005-24 | 25/03/2024 | SCM | permanent | major | Additional source induction of Vitamin D3 | We are currently procuring Nutraceutical material Vitamin D3 powder 100,000 IU/g from M/s. DSM nutritional product and Zhejiang garden biochemical high tech Co Ltd.
Moreover, we have item description with brand name i-e Vitamin D3 powder 100 SDS (DRY) | we intent to induct one more source M/s Xiamen kingbomway biotech Co., Ltd.No.299 west Yangguang road, Haicang, Xiamen, China
Moreover, we propose to change item description from vitamin D3 powder 10SDS (DRY) to Vitamin D3 powder 100,000 IU/g | N/A | Approved | | Opened | Nutra | 1.
Source approval documents are required along with all the technical documents SCM
2. Approved vendor list will update QA
3. Procurement of material to conduct commercial batch manufacturing SCM
4. Process validation will be performed QA
5. Stability of product will be charged QC
|
|
| 27/03/2024 | | Hafsa Fatima | |
|
| CMN-0006-24 | 29/05/2024 | Business Development | Permanent | Major | Revision in artworks of Sparliv Tablets & Vible Tablets | 1. Existing artworks of Sparliv & Vible does not contains statement regarding desiccant bag.
2. Storage conditions on existing artworks are mentioned as "Store below 30°C | 1. This statement will be added on artworks of Sparliv & Vible "Always keep the desiccant bag
inside the bottle" has been added.
2. Storage conditions will be updated to "Store below 25°C". | N/A | Approved | 28/06/2024 | Opened | Nutra |
|
|
| 29/05/2024 | | Hafsa Fatima | |
|
| CMN-0007-24 | 28/06/2024 | Product Development | Permanent | Major | Change in formulation of Finno-Q Sachet | Currently, formulation of Finno-Q sachet contains coated ascorbic acid.Complete formulation is attached in annexure-1. | It is proposed to remove coated ascorbic acid and add citric acid anhydrous as per formulation attached in annexure-1. | RA-0028-24 | Approved | | Opened | Nutra |
|
|
| 28/06/2024 | | Zafran Meer | |
|
| CMN-0008-24 | 12/07/2024 | SCM | Permanent | Major | Discontinuation of Flavor Orange Durarome 861994 TD 0991 and development of alternate source | Currently we have approved Flavor Orange Durarome 861994 TD 0991 for Nutraceutical products (list of products attached) from Manufacturer M/S. DSM Firmenich. | Development of alternate source of flavor with another product code i.e Orange Durarome Flavor 858024 TDB 0594 with same specification and Manufacturer M/S. DSM Firmenich.
Sample has been submitted and PD trial and initial test results have been approved.
| | | | In Progress | Nutra |
|
|
| 12/07/2024 | | Zafran Meer | |
|
| CMN-0009-24 | 03/08/2024 | BD | Permanent | Major | New products launch in Ghana | The below mentioned products are not launched in Ghana yet.
1. Ferfer Sachets
2. Evomag Sachet | It is proposed to launch these products in Ghana. | N/A | Approved | | In Progress | Nutra | 1) Registration Letter required RA 2) Product launch in ghana. BD 3) Development and approval of artwork BD 4) Item code will open for new developed artwork QC 5) FG codes will be opened SCM 6) Specification will be updated QC 7) BOM will create on SAP QA 8) BPR will be prepared QA 9) Shelf life for export product list will be updated. QA
| 1) Registration letter received for both products.
3) Development and approval of artwork for both products.
4) Item codes is opened for both products.
5) FG codes is opened for both products.
7) BOM has been created for both products.
| Timelines for ferfer sachet: 1) Already registered 2) Oct-24 3) Done 4) Done 5) Sep-24 6) Dec-24 7) Dec-24 8) Dec-24 9) Jan-25 Timelines for Evomag Sachet: 1) Already registered 2) Dec-24 3) Aug-24 4) Aug-24 5) Sep-24 6) Dec-24 7) Dec-24 8) Dec-24 9) Jan-25 0
| 03/08/2024 | 18/11/2024 | Hamza Ahmed | Hamza Ahmed |
|
| CMN-0010-24 | 03/08/2024 | BD | Permanent | Major | New Products launch in Tajikistan | The products mentioned in the attached list are not launched in Tajikistan. | It is proposed to launch these products in Tajikistan. | N/A | Approved | | In Progress | Nutra | 1) Registration Letter required RA 2) Product launch in Tajikistan. BD 3) Development and approval of artwork BD 4) Item code will open for new developed artwork QC 5) FG codes will be opened SCM 6) Specification will be updated QC 7) BOM will create on SAP QA 8) BPR will be prepared QA 9) Shelf life for export product list will be updated. QA
| 3) Artwork has been developed for all five products.
4) Items codes has been opened for all five products.
5) FG codes has been opened for all five products.
7) BOM has been developed for all five products.
| Timelines are same for all products:
1) Dec-24
2) Dec-24
3) Aug-24
4) Aug-24
5) Sep-24
6) Mar-25
7) Dec-24
8) Dec-24
9) Jan-25
| 03/08/2024 | 18/11/2024 | Hamza Ahmed | Hamza Ahmed |
|
| CMN-0011-24 | 09/10/2024 | BD | Permanent | | Launch of New Products in UAE. | The products mentioned in the attached list are not launched in UAE yet. | These products are planned for launch in UAE. | N/A | under Approval | | | Nutra |
|
|
| 09/10/2024 | | Hamza Ahmed | |
|
| CMN-0012-24 | 09/10/2024 | BD | Permanent | | Launch of New Products in Qatar. | The products mentioned in the attached list are not launched in Qatar yet. | These products are planned for launch in Qatar. | N/A | under Approval | | | Nutra |
|
|
| 09/10/2024 | | Hamza Ahmed | |
|
| CMN-0013-24 | 09/10/2024 | BD | Permanent | | Launch of New Products in Ethiopia | The products mentioned in the attached list are not launched in Ethiopia yet. | These products are planned for launch in Ethiopia. | N/A | under Approval | | | Nutra |
|
|
| 09/10/2024 | | Hamza Ahmed | |
|
| CMN-0014-24 | 01/11/2024 | SCM | Permanent | | Addition of Manufacturer Name for Tribasic calcium phosphate | We have approved Supplier by the name of M/s JRS Pharma GmbH & Co. KG for Nutra Excipient Tribasic calcium phosphate which is getting Toll Manufactured by Sudeep Pharma Pvt Ltd | We intend to Procure Tribasic calcium phosphate with same Specifications directly from Sudeep Pharma Pvt Ltd and propose to add Sudeep Pharma Pvt Ltd in Nutra Vendor List.
Sudeep Pharma Private Limited, Address: 129/1/A & 129/12, 13, 14, 15 GIDC Estate, Nandesari-391340, Vadodara, Gujarat, India
| N/A | under Approval | | In Progress | Nutra |
|
|
| 02/11/2024 | 02/11/2024 | Hamza Ahmed | Hamza Ahmed |
|
| CMN-0015-24 | 01/11/2024 | PD | Permanent | | Change in formulation of K-1000 Chewable Tablet. | Currently, K-1000 Chewable Tablet is being manufactured by Calcium Carbonate 92.5%, Xylitab 200 and Aspartame as per the formulation attached in annexure I. | It is proposed to replace Calcium carbonate (92.5%) and aspartame with Calcium carbonate (95%) and sucralose, respectively. Additionally, mannitol (Pearlitol) will be incorporated as mentioned in the formulation attached in Annexure I. | N/A | under Approval | | In Progress | Nutra |
|
|
| 02/11/2024 | | Hamza Ahmed | |
|
| CMN-0016-24 | 05/12/2024 | PD | Permanent | | Change in formulation and revised artwork of Femova Sachet.
| Currently, Femova Sachet is being manufactured as per the formulation attached in annexure I. | It is proposed to revise formulation of Femova Sachet by replacing citric acid and sodium citrate with ascorbic acid and aspartame with sucralose. Butylated hydroxyanisole is also added in formulation as mentioned in Annexure I.
Orange Durarome Flavour 858024TDB0594 will be used with 20% less quantity as per CMN-0008-24.
Artwork to be revised mentioning storage condition as “Store below 25?.”
| | under Approval | | | Nutra |
|
|
| 05/12/2024 | | Hamza Ahmed | |